Literature DB >> 12123105

Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi Teaching Hospital.

A T Eltahawy1.   

Abstract

OBJECTIVE: To determine the resistance rate of the most commonly used antimicrobial agents amongst Helicobacter pylori isolates.
METHODS: The agar disk diffusion method (Kirby Bauer) was utilized to determine the susceptibility of 223 H. pylori strains isolated before treatment. Isolates were tested against metronidazole (5 micrograms), clarithromycin (15 micrograms), amoxycillin (10 micrograms), and tetracycline (30 micrograms).
RESULTS: The resistance rate was 80% for metronidazole and 4% for clarithromycin. Tetracycline and amoxycillin showed very low degree of resistance with 1 (0.4%) and 3 (1.3%) of the strains resistant to these antibiotics, respectively. Age, sex and ethnicity had a remarkable effect on the resistance rate.
CONCLUSION: The results indicate that metronidazole and clarithromycin should not be used as the only antimicrobial agents in the treatment of H. pylori infection. Susceptibility testing using the disk diffusion method is cost-effective in the screening of antimicrobial resistance against H. pylori.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123105     DOI: 10.1159/000058009

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  5 in total

1.  Helicobacter pylori antibiotic resistance in Iran.

Authors:  Marjan Mohammadi; Delaram Doroud; Nazanin Mohajerani; Sadegh Massarrat
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 2.  Helicobacter pylori eradication in West Asia: a review.

Authors:  Hafez Fakheri; Zohreh Bari; Mohsen Aarabi; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt.

Authors:  May Sherif; Zaynab Mohran; Hanan Fathy; David M Rockabrand; Patrick J Rozmajzl; Robert W Frenck
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 4.  Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.

Authors:  Muhammad Miftahussurur; Yoshio Yamaoka
Journal:  Molecules       Date:  2015-04-08       Impact factor: 4.411

5.  Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection.

Authors:  Fahad Alsohaibani; Hamad Al Ashgar; Khalid Al Kahtani; Ingvar Kagevi; Musthafa Peedikayil; Abdulrahman Alfadda; Mohammed Khan
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.